The present study investigated whether pharmacological postconditoning with
netrin-1 is cardioprotective against
ischemia reperfusion (I/R) injury, and the underlying signaling mechanisms. Langendorff perfused hearts isolated from wild-type (WT) C57BL/6 or DCC+/- mice underwent a 20-min of
ischemia, followed by a 60-min of reperfusion, in the presence or absence of
netrin-1, or
netrin-1 in combination with
U0126 (MEK1/2 inhibitor), or
PTIO (
nitric oxide/NO scavenger). In WT mice,
netrin-1 postconditioning dramatically reduced
infarct size to 17.0±2.5%, from 40.5±4.2% in the untreated I/R group.
U0126 or
PTIO alone had no effect on
infarct size but abolished the effects of
netrin-1. The protective effect of
netrin-1 was markedly diminished in DCC+/- mice (44.5±2% vs. 15±2.6 % for infract size in DCC+/- vs. DCC+/+ group). Our results indicate that
netrin-1, given as a pharmacological postconditioning agent, induces cardioprotection via a DCC-dependent mechanism that involves ERK1/2 activation and NO production. Combined with our previous findings,
netrin-1 treatment proves to be extremely and consistently beneficial whenever delivered to the heart, establishing its substantial promises for being developed into a robust therapeutic strategy for acute
myocardial infarction.